INSP vs. HAE, MMSI, GKOS, PRCT, AXNX, TNDM, IRTC, NARI, ICUI, and NVCR
Should you be buying Inspire Medical Systems stock or one of its competitors? The main competitors of Inspire Medical Systems include Haemonetics (HAE), Merit Medical Systems (MMSI), Glaukos (GKOS), PROCEPT BioRobotics (PRCT), Axonics (AXNX), Tandem Diabetes Care (TNDM), iRhythm Technologies (IRTC), Inari Medical (NARI), ICU Medical (ICUI), and NovoCure (NVCR). These companies are all part of the "surgical & medical instruments" industry.
Haemonetics (NYSE:HAE) and Inspire Medical Systems (NYSE:INSP) are both mid-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, community ranking, profitability, dividends, valuation, analyst recommendations, earnings and media sentiment.
99.7% of Haemonetics shares are owned by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are owned by institutional investors. 1.8% of Haemonetics shares are owned by company insiders. Comparatively, 4.1% of Inspire Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Haemonetics presently has a consensus price target of $108.67, suggesting a potential upside of 22.08%. Inspire Medical Systems has a consensus price target of $256.53, suggesting a potential upside of 62.41%. Given Haemonetics' stronger consensus rating and higher possible upside, analysts plainly believe Inspire Medical Systems is more favorable than Haemonetics.
Haemonetics has a beta of 0.34, indicating that its share price is 66% less volatile than the S&P 500. Comparatively, Inspire Medical Systems has a beta of 1.35, indicating that its share price is 35% more volatile than the S&P 500.
In the previous week, Haemonetics had 5 more articles in the media than Inspire Medical Systems. MarketBeat recorded 15 mentions for Haemonetics and 10 mentions for Inspire Medical Systems. Haemonetics' average media sentiment score of 1.26 beat Inspire Medical Systems' score of 0.53 indicating that Inspire Medical Systems is being referred to more favorably in the news media.
Haemonetics received 206 more outperform votes than Inspire Medical Systems when rated by MarketBeat users. However, 61.03% of users gave Inspire Medical Systems an outperform vote while only 60.89% of users gave Haemonetics an outperform vote.
Haemonetics has higher revenue and earnings than Inspire Medical Systems. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.
Haemonetics has a net margin of 8.98% compared to Haemonetics' net margin of -2.38%. Inspire Medical Systems' return on equity of 22.25% beat Haemonetics' return on equity.
Summary
Haemonetics beats Inspire Medical Systems on 10 of the 18 factors compared between the two stocks.
Get Inspire Medical Systems News Delivered to You Automatically
Sign up to receive the latest news and ratings for INSP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding INSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Inspire Medical Systems Competitors List
Related Companies and Tools
